Helo Corp. s Patent Pending Side Sensor Enables Vascular Age Assessment on its Vyvo Life Watch 2
Life Sensing Technology
TM and dedicated to improving wellness worldwide, is pleased to announce that with its latest Vyvo Smart app update, it provides rapid, non-invasive Vascular Age assessment to all Vyvo Life Watch 2 users worldwide.
Vyvo s patent-pending side sensor captures high-quality fingertip photoplethysmogram (PPG) signals
[1] on demand. Accelerated Plethysmography
[2] (APG), which uses the second derivative of PPG waveform, is used to analyze the wearer s arterial stiffness and estimate their Vascular Age. The whole process takes less than a minute.
Figure: Vyvo Life Watch 2 with patent-pending side sensor and APG result displayed on the Vyvo Smart app.
(2)
SAN FRANCISCO
, CA / ACCESSWIRE / February 2, 2021 / Helo Corp. (OTC PINK:HLOC) ( Helo or the Company), a leading developer of wearable wireless devices embedded with Life Sensing Technology
TM and dedicated to improving wellness worldwide, is pleased to announce that Vyvo has received a Platinum and Two Gold awards at the 15th annual AVA Digital Awards.
One of the Vyvo Life Watch videos can be viewed below[1]:
For more detailed information and a complete list of winners honoring web production, digital marketing, digital video creation, pro-bono excellence, administered by the Association of Marketing and Communication Professionals, please visit: https://avaawards.com.
The AVA Awards were awarded for Vyvo s Life Watch digital campaign launch and had been awarded a Platinum Award for the category of Digital Video Creation, Motion Graphics Product. Vyvo also received two Golds: the first for their Social Campaign in the category of Video Production, Commercials, Product,
Vyvo Becomes Publicly Traded in a Transaction Valued at $50 Million with Helo Corp.
SAN FRANCISCO, CA / ACCESSWIRE / January 14, 2021 / Helo Corp. (OTC PINK:HLOC) ( Helo or the Company), a leading developer of wearable wireless devices embedded with Life Sensing Technology
TM and dedicated to improving wellness worldwide, is pleased to announce the closing of its acquisition of Vyvo Inc. ( Vyvo ) on January 1, 2021, which transfers the Vyvo business into a publicly traded entity. Vyvo is building a worldwide community of passionate users who leverage technology to live healthier and happier lives with greater prosperity.
The all stock transaction encompasses the issuance by Helo of 50 million common shares, 100 Preferred A Super Voting shares and 2 million Preferred B shares in exchange for Vyvo s strategic assets, including patents, technologies and operational assets. These assets include Nutramatic, GlucoStrap, Artificial Intelligence(AI) protocols and machine learning proces